White label – Pompe disease - ClinicalTrials.eu

Study Comparing Ceralasertib and Durvalumab with Docetaxel for Patients with Advanced Non-Small Cell Lung Cancer After Previous Treatments

Not recruiting

3 1 1 1
Investigated Diseases:
- Non-small cell lung cancer metastatic
Investigated Drugs:
+4
Study of anakinra safety and effectiveness given by injection under the skin in patients with cystic fibrosis

Not recruiting

2 1 1
Investigated Diseases:
- Cystic fibrosis
Investigated Drugs:
- Anakinra
Study on the Effectiveness and Safety of Ocrelizumab for Adults with Primary Progressive Multiple Sclerosis

Not recruiting

3 1 1
Investigated Diseases:
- Primary progressive multiple sclerosis
Investigated Drugs:
+3
Study on the Effects of Satralizumab for Patients with Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD)

Not recruiting

3 1 1
Investigated Diseases:
- Autoimmune demyelinating disease
Study on the Effects of VAY736 for Patients with Autoimmune Hepatitis Who Do Not Respond Well to Standard Treatment

Not recruiting

4 1
Investigated Diseases:
- Autoimmune hepatitis
Investigated Drugs:
- Ianalumab
Study on How Concizumab Works for Patients with Hemophilia A or B with Inhibitors

Not recruiting

3 1 1
Investigated Drugs:
- Concizumab
+2
Study on Durvalumab and Domvanalimab for Patients with Stage III Unresectable Non-Small Cell Lung Cancer After Chemoradiation Therapy

Not recruiting

3 1 1
Investigated Diseases:
- Lung neoplasm malignant
Investigated Drugs:
+4
Study on the Safety and Effectiveness of Rozanolixizumab in Children with Generalized Myasthenia Gravis

Not recruiting

4 1 1 1
Investigated Diseases:
- Myasthenia gravis
Investigated Drugs:
- Immunoglobulins, Normal Human
- Rozanolixizumab
Study on Methotrexate and Glucocorticoid Combination for Early Rheumatoid Arthritis, with Optional Etanercept for Non-Responders

Not recruiting

3 1 1 1
Investigated Drugs:
- Leflunomide
- Etanercept
Study on Pembrolizumab, Etoposide, and Cisplatin or Carboplatin for First-Line Treatment in Patients with Extensive-Stage Small Cell Lung Cancer

Not recruiting

2 1 1 1
Investigated Diseases:
- Small cell lung cancer
Investigated Drugs:

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies